Safety and feasibility of minimally invasive lobectomy after neoadjuvant immunotherapy for non-small cell lung cancer.

Camille Mathey-Andrews,Meghan McCarthy,Alexandra L Potter,Jorind Beqari,Sean C Wightman,Douglas Liou,Vignesh Raman,Chi-Fu Jeffrey Yang

The Journal of thoracic and cardiovascular surgery（2022）

引用 1|浏览6

暂无评分

摘要

In this national analysis, neoadjuvant immunotherapy for resectable NSCLC was not associated with an increased likelihood of the need for thoracotomy, conversion from MIS to open lobectomy, or inferior perioperative outcomes.

查看译文

关键词

immunotherapy,minimally invasive surgery,neoadjuvant,non–small cell lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要